Search

Free Shipping On All Orders Over $100
GET 20% OFF WHEN YOU SPEND $500 OR MORE

In Stock

Buy Verquvo (vericiguat) Online

5 Reviews

DISEASE INDICATIONS: Risk of cardiovascular events

MANUFACTURER: Merck

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Verquvo (vericiguat) is a prescription medication used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). CHF is a condition in which the heart muscle is weakened and cannot pump blood as efficiently as it should. HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should.

From $284.99

Clear

Verquvo (vericiguat) is a prescription medication used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). CHF is a condition in which the heart muscle is weakened and cannot pump blood as efficiently as it should. HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should.

Description

Verquvo is a soluble guanylate cyclase (sGC) stimulator. sGC is an enzyme that produces cyclic guanosine monophosphate (cGMP), a molecule that helps to relax blood vessels and improve heart function. Verquvo works by directly stimulating sGC, which increases the production of cGMP. This can lead to improved heart function, reduced blood pressure, and decreased symptoms of CHF.

Uses

Verquvo is used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should. Verquvo can be used in combination with other CHF medications, such as beta-blockers, ACE inhibitors, and angiotensin receptor blockers (ARBs).

How to use

Verquvo is taken orally once daily with food. The recommended starting dose is 2.5 mg. The dose can be doubled every 2 weeks until the target maintenance dose of 10 mg is reached. The dose may need to be adjusted based on the patient’s tolerability.

Dosage

The recommended starting dose of Verquvo is 2.5 mg orally once daily with food. The dose can be doubled every 2 weeks until the target maintenance dose of 10 mg is reached. The dose may need to be adjusted based on the patient’s tolerability.

Mechanism of action

Verquvo works by directly stimulating soluble guanylate cyclase (sGC), an enzyme that produces cyclic guanosine monophosphate (cGMP). cGMP is a molecule that helps to relax blood vessels and improve heart function. By increasing the production of cGMP, Verquvo can improve heart function, reduce blood pressure, and decrease symptoms of CHF.

Storage conditions

Verquvo should be stored at room temperature (68°F to 77°F) away from light and moisture.

Precautions

Verquvo can cause hypotension (low blood pressure). Patients should be monitored for signs and symptoms of hypotension, such as dizziness, lightheadedness, and fainting. If hypotension occurs, the dose of Verquvo may need to be reduced or discontinued.

Verquvo can also cause anemia. Patients should be monitored for signs and symptoms of anemia, such as fatigue, shortness of breath, and pale skin. If anemia occurs, the dose of Verquvo may need to be reduced or discontinued.

Interactions

Verquvo can interact with other medications, such as nitrates, alpha-blockers, and certain antihypertensives. Patients should tell their doctor about all of the medications they are taking before starting Verquvo.

Contraindications

Verquvo is contraindicated in patients with the following conditions:

  • Hypotension (low blood pressure) with systolic blood pressure less than 90 mmHg
  • Severe aortic stenosis
  • Severe pulmonary hypertension
  • Pregnancy
  • Lactation

Side effects

The most common side effects of Verquvo are:

  • Hypotension (low blood pressure)
  • Anemia
  • Headache
  • Dizziness
  • Nausea
  • Diarrhea
  • Edema (swelling)

Overdose

There is no known specific antidote for Verquvo overdose. Treatment should be supportive and include monitoring of vital signs, fluid replacement, and vasopressor therapy if needed.

If you have any questions or concerns about Verquvo, please talk to your doctor.

Package

14 tablets of 2.5 mg, 14 tablets of 5 mg, 30 count bottle of 2.5 mg tablets, 30 count bottle of 5 mg tablets, 30 count bottle of 10 mg tablets, 90 count bottle of 10 mg tablets, 98 tablets x 5 mg

Latest reviews

  1. Isabelle Thornton

    Verquvo has exceeded my expectations as part of my heart failure treatment plan. Since beginning therapy, I’ve experienced fewer limitations during everyday activities, and my energy level has steadily improved. My routine follow-up visits and lab work have all been encouraging, and my cardiologist believes the medication has contributed positively to keeping my condition stable. While I know managing heart failure requires a comprehensive approach, Verquvo has become an important piece of that plan. I feel more optimistic about the future and highly appreciate the benefits this medication has provided.

  2. Nolan Beckett

    Verquvo has made a meaningful difference in my life. Before starting treatment, even simple activities like climbing a few stairs would leave me exhausted. After several months on the medication, combined with my other heart failure therapies, I’ve noticed gradual but consistent improvement. My cardiologist says my overall condition has remained stable, and I feel much more confident participating in family activities again. The medication has been easy to incorporate into my daily schedule, and I haven’t experienced any significant side effects. I’m grateful to have this treatment available.

  3. Colette Winslow

    My doctor recommended Verquvo after discussing additional treatment options for my chronic heart failure with reduced ejection fraction. The transition was smooth, and I’ve tolerated the medication very well. Over time, I’ve noticed that I can stay active longer without becoming overly fatigued, and I haven’t experienced the same level of breathlessness that used to limit my daily routine. My regular heart checkups have been reassuring, and my healthcare team continues to be pleased with my response to treatment. Overall, I couldn’t be happier with my experience.

  4. Declan Rowe

    Living with heart failure has required major lifestyle adjustments, but Verquvo has been an excellent addition to my overall treatment. Since starting the medication, I feel more energetic during the day and can complete everyday tasks with less shortness of breath. My cardiologist has been very satisfied with my progress during each follow-up visit, and my condition has remained stable. I continue following my diet, exercise recommendations, and other medications, and Verquvo has become an important part of keeping everything on track. I’m very thankful for the positive results.

  5. Mallory Kensington

    After being hospitalized for chronic heart failure, my cardiologist added Verquvo to my treatment plan. Over the following months, I noticed steady improvements in my endurance and daily activities. Walking around my neighborhood became much easier, and I wasn’t as easily exhausted as before. My follow-up appointments have been encouraging, and my doctor is pleased with how well my heart failure is being managed. I also appreciate that the medication has fit smoothly into my existing routine without causing significant problems. Verquvo has helped me regain confidence and enjoy a much better quality of life.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Orladeyo (berotralstat) Online

$17,967.38
(2 Reviews)
MANUFACTURER: BioCryst Pharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Orladeyo is a prescription medication used to prevent attacks of hereditary angioedema in adults and children by reducing the frequency of attacks. It is a subcutaneous injection that works by inhibiting kallikrein, an enzyme involved in the production of bradykinin.

Buy Verquvo (vericiguat) Online

From $284.99
(5 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events MANUFACTURER: Merck USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Verquvo (vericiguat) is a prescription medication used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). CHF is a condition in which the heart muscle is weakened and cannot pump blood as efficiently as it should. HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should.

Buy Repatha SureClick (evolocumab) Online

$629.98
(3 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events, Hypercholesterolemia MANUFACTURER: Amgen Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Repatha is a subcutaneous injection used to lower LDL cholesterol levels in adults with primary hyperlipidemia or mixed dyslipidemia and in individuals with clinical atherosclerotic cardiovascular disease who require additional LDL cholesterol reduction. It binds to and inhibits PCSK9, promoting the clearance of LDL cholesterol from the bloodstream.

Buy Vascepa (icosapent ethyl) Online

From $530.34
(5 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events, Hypertriglyceridemia MANUFACTURER: Amarin Pharma Inc USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Vascepa (icosapent ethyl) is a medication used to reduce the risk of cardiovascular events in adults with established cardiovascular disease or elevated triglyceride levels.

Buy Entresto (sacubitril/valsartan) Online

From $148.92
(3 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.

Buy Nexletol (bempedoic acid) Online

$426.42
(4 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Esperion Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Nexletol is a prescription medication used to lower cholesterol levels in patients with hypercholesterolemia.

Back to Top
Product has been added to your cart